期刊文献+

Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy 被引量:11

Functions of Müller cell-derived vascular endothelial growth factor in diabetic retinopathy
下载PDF
导出
摘要 Müller cells are macroglia and play many essential roles as supporting cells in the retina.To respond to pathological changes in diabetic retinopathy(DR),a major complication in the eye of diabetic patients,retinal Müller glia produce a high level of vascular endothelial growth factor(VEGF or VEGF-A).As VEGF is expressed by multiple retinal cell-types and Müller glia comprise only a small portion of cells in the retina,it has been a great challenge to reveal the function of VEGF or other globally expressed proteins produced by Müller cells.With the development of conditional gene targeting tools,it is now possible to dissect the function of Müller cell-derived VEGF in vivo.By using conditional gene targeting approach,we demonstrate that Müller glia are a major source of retinal VEGF in diabetic mice and Müller cell-derived VEGF plays a significant role in the alteration of protein expression and peroxynitration,which leads to retinal inflammation,neovascularization,vascular leakage,and vascular lesion,key pathological changes in DR.Therefore,Müller glia are a potential cellular target for the treatment of DR,a leading cause of blindness. Müller cells are macroglia and play many essentialroles as supporting cells in the retina. To respond topathological changes in diabetic retinopathy (DR), amajor complication in the eye of diabetic patients,retinal Müller glia produce a high level of vascularendothelial growth factor (VEGF or VEGF-A). As VEGFis expressed by multiple retinal cell-types and Müllerglia comprise only a small portion of cells in the retina,it has been a great challenge to reveal the function ofVEGF or other globally expressed proteins produced byMüller cells. With the development of conditional genetargeting tools, it is now possible to dissect the functionof Müller cell-derived VEGF in vivo . By using conditionalgene targeting approach, we demonstrate that Müllerglia are a major source of retinal VEGF in diabetic miceand Müller cell-derived VEGF plays a significant role inthe alteration of protein expression and peroxynitration,which leads to retinal inflammation, neovascularization,vascular leakage, and vascular lesion, key pathologicalchanges in DR. Therefore, Müller glia are a potentialcellular target for the treatment of DR, a leading causeof blindness.
出处 《World Journal of Diabetes》 SCIE CAS 2015年第5期726-733,共8页 世界糖尿病杂志(英文版)(电子版)
基金 Supported by The NIH grants,Nos.GM104934,EY020900 and EY021725(NEI Core) Chinese National Natural Science Foundation grant,No.81200699 grants from Presbyterian Health Foundation and Oklahoma Center for Adult Stem Cell Research and an endowment from Choctaw Nation(to Le YZ)
关键词 Müller GLIA Vascular ENDOTHELIAL growthfactor Protein modification Inflammation Blood-retinabarriers DIABETIC RETINOPATHY Müller glia Vascular endothelial growth factor Protein modification Inflammation Blood-retina barriers Diabetic retinopathy
  • 相关文献

参考文献66

  • 1Reichenbach A, Bringmann A. New functions of Müller cells. Glia2013; 61: 651-678 [PMID: 23440929 DOI: 10.1002/glia.22477].
  • 2Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW.Diabetic retinopathy: more than meets the eye. Surv Ophthalmol2002; 47 Suppl 2: S253-S262 [PMID: 12507627 DOI: 10.1016/S0039-6257(02)00387-9].
  • 3Xu HZ, Le YZ. Significance of outer blood-retina barrier breakdownin diabetes and ischemia. Invest Ophthalmol Vis Sci 2011; 52:2160-2164 [PMID: 21178141 DOI: 10.1167/iovs.10-6518].
  • 4Xu HZ, Song Z, Fu S, Zhu M, Le YZ. RPE barrier breakdown indiabetic retinopathy: seeing is believing. J Ocul Biol Dis Infor 2011; 4:83-92 [PMID: 23275801 DOI: 10.1007/s12177-011-9068-4].
  • 5Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, SambamurtiK. Pigment epithelium-derived factor maintains retinal pigmentepithelium function by inhibiting vascular endothelial growthfactor-R2 signaling through gamma-secretase. J Biol Chem2009; 284: 30177-30186 [PMID: 19723623 DOI: 10.1074/jbc.M109.032391].
  • 6Ozdemir H, Karacorlu M, Karacorlu S. Serous macular detachmentin diabetic cystoid macular oedema. Acta Ophthalmol Scand 2005;83: 63-66 [PMID: 15715559 DOI: 10.1111/j.1600-0420.2005.00387.x].
  • 7Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Deathof retinal neurons in streptozotocin-induced diabetic mice. InvestOphthalmol Vis Sci 2004; 45: 3330-3336 [PMID: 15326158 DOI:10.1167/iovs.04-0247].
  • 8Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, NakamuraM. New insights into the pathophysiology of diabetic retinopathy:potential cell-specific therapeutic targets. Diabetes Technol Ther2000; 2: 601-608 [PMID: 11469624 DOI: 10.1089/15209150050502023].
  • 9Terasaki H, Hirose H, Miyake Y. S-cone pathway sensitivity indiabetes measured with threshold versus intensity curves on flashedbackgrounds. Invest Ophthalmol Vis Sci 1996; 37: 680-684 [PMID:8595969].
  • 10Aspinall PA. Rod-cone interaction: some indirect evidence. ActaOphthalmol (Copenh) 1977; 55: 294-302 [PMID: 577101 DOI:10.1111/j.1755-3768.1977.tb01311.x].

同被引文献69

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部